CD8A and malignant colon neoplasm: TAT-APC11 also showed the most effective tumor suppression (Supplementary information, Fig. S8b, c) and augmentation of intratumoral CD8+ T cell infiltration (Supplementary information, Fig. S8d, e) in a syngeneic mouse colon cancer model.